168 related articles for article (PubMed ID: 9694158)
1. FADD gene therapy for malignant gliomas in vitro and in vivo.
Kondo S; Ishizaka Y; Okada T; Kondo Y; Hitomi M; Tanaka Y; Haqqi T; Barnett GH; Barna BP
Hum Gene Ther; 1998 Jul; 9(11):1599-608. PubMed ID: 9694158
[TBL] [Abstract][Full Text] [Related]
2. Apoptosis by retrovirus- and adenovirus-mediated gene transfer of Fas ligand to glioma cells: implications for gene therapy.
Shinoura N; Yoshida Y; Sadata A; Hanada KI; Yamamoto S; Kirino T; Asai A; Hamada H
Hum Gene Ther; 1998 Sep; 9(14):1983-93. PubMed ID: 9759926
[TBL] [Abstract][Full Text] [Related]
3. Fas/APO-1 gene transfer for human malignant glioma.
Weller M; Malipiero U; Rensing-Ehl A; Barr PJ; Fontana A
Cancer Res; 1995 Jul; 55(13):2936-44. PubMed ID: 7540953
[TBL] [Abstract][Full Text] [Related]
4. A novel treatment of human malignant gliomas in vitro and in vivo: FADD gene transfer under the control of the human telomerase reverse transcriptase gene promoter.
Komata T; Koga S; Hirohata S; Takakura M; Germano IM; Inoue M; Kyo S; Kondo S; Kondo Y
Int J Oncol; 2001 Nov; 19(5):1015-20. PubMed ID: 11605003
[TBL] [Abstract][Full Text] [Related]
5. Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines.
Weller M; Frei K; Groscurth P; Krammer PH; Yonekawa Y; Fontana A
J Clin Invest; 1994 Sep; 94(3):954-64. PubMed ID: 7521890
[TBL] [Abstract][Full Text] [Related]
6. Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1.
Zhang J; Cado D; Chen A; Kabra NH; Winoto A
Nature; 1998 Mar; 392(6673):296-300. PubMed ID: 9521326
[TBL] [Abstract][Full Text] [Related]
7. Protooncogene bcl-2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation.
Weller M; Malipiero U; Aguzzi A; Reed JC; Fontana A
J Clin Invest; 1995 Jun; 95(6):2633-43. PubMed ID: 7539458
[TBL] [Abstract][Full Text] [Related]
8. Endogenous expression of transforming growth factor beta1 inhibits growth and tumorigenicity and enhances Fas-mediated apoptosis in a murine high-grade glioma model.
Ashley DM; Kong FM; Bigner DD; Hale LP
Cancer Res; 1998 Jan; 58(2):302-9. PubMed ID: 9443409
[TBL] [Abstract][Full Text] [Related]
9. Novel gene therapy for rheumatoid arthritis by FADD gene transfer: induction of apoptosis of rheumatoid synoviocytes but not chondrocytes.
Kobayashi T; Okamoto K; Kobata T; Hasunuma T; Kato T; Hamada H; Nishioka K
Gene Ther; 2000 Mar; 7(6):527-33. PubMed ID: 10757027
[TBL] [Abstract][Full Text] [Related]
10. Carboplatin induces Fas (APO-1/CD95)-dependent apoptosis of human tongue carcinoma cells: sensitization for apoptosis by upregulation of FADD expression.
Mishima K; Nariai Y; Yoshimura Y
Int J Cancer; 2003 Jul; 105(5):593-600. PubMed ID: 12740905
[TBL] [Abstract][Full Text] [Related]
11. FADD gene therapy using the human telomerase catalytic subunit (hTERT) gene promoter to restrict induction of apoptosis to tumors in vitro and in vivo.
Koga S; Hirohata S; Kondo Y; Komata T; Takakura M; Inoue M; Kyo S; Kondo S
Anticancer Res; 2001; 21(3B):1937-43. PubMed ID: 11497281
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation of FADD/MORT1 and Fas by kinases that associate with the membrane-proximal cytoplasmic domain of Fas.
Kennedy NJ; Budd RC
J Immunol; 1998 May; 160(10):4881-8. PubMed ID: 9590235
[TBL] [Abstract][Full Text] [Related]
13. The interferon-induced protein kinase (PKR), triggers apoptosis through FADD-mediated activation of caspase 8 in a manner independent of Fas and TNF-alpha receptors.
Gil J; Esteban M
Oncogene; 2000 Jul; 19(32):3665-74. PubMed ID: 10951573
[TBL] [Abstract][Full Text] [Related]
14. Activation of the dsRNA-dependent protein kinase, PKR, induces apoptosis through FADD-mediated death signaling.
Balachandran S; Kim CN; Yeh WC; Mak TW; Bhalla K; Barber GN
EMBO J; 1998 Dec; 17(23):6888-902. PubMed ID: 9843495
[TBL] [Abstract][Full Text] [Related]
15. FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis.
Chinnaiyan AM; Tepper CG; Seldin MF; O'Rourke K; Kischkel FC; Hellbardt S; Krammer PH; Peter ME; Dixit VM
J Biol Chem; 1996 Mar; 271(9):4961-5. PubMed ID: 8617770
[TBL] [Abstract][Full Text] [Related]
16. Retroviral transfer of CPP32beta gene into malignant gliomas in vitro and in vivo.
Kondo S; Tanaka Y; Kondo Y; Ishizaka Y; Hitomi M; Haqqi T; Liu J; Barnett GH; Alnemri ES; Barna BP
Cancer Res; 1998 Mar; 58(5):962-7. PubMed ID: 9500457
[TBL] [Abstract][Full Text] [Related]
17. Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression.
Fulda S; Meyer E; Debatin KM
Cancer Res; 2000 Jul; 60(14):3947-56. PubMed ID: 10919673
[TBL] [Abstract][Full Text] [Related]
18. An apoptosis signaling pathway induced by the death domain of FADD selectively kills normal but not cancerous prostate epithelial cells.
Morgan MJ; Thorburn J; Thomas L; Maxwell T; Brothman AR; Thorburn A
Cell Death Differ; 2001 Jul; 8(7):696-705. PubMed ID: 11464214
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylation of FADD/ MORT1 at serine 194 and association with a 70-kDa cell cycle-regulated protein kinase.
Scaffidi C; Volkland J; Blomberg I; Hoffmann I; Krammer PH; Peter ME
J Immunol; 2000 Feb; 164(3):1236-42. PubMed ID: 10640736
[TBL] [Abstract][Full Text] [Related]
20. Protection against Fas/APO-1- and tumor necrosis factor-mediated cell death by a novel protein, sentrin.
Okura T; Gong L; Kamitani T; Wada T; Okura I; Wei CF; Chang HM; Yeh ET
J Immunol; 1996 Nov; 157(10):4277-81. PubMed ID: 8906799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
